Changes in quality of life in patients with acromegaly after surgical remission - A prospective study using SF-36 questionnaire

被引:19
作者
Fujio, Shingo [1 ]
Arimura, Hiroshi [2 ]
Hirano, Hirofumi [1 ]
Habu, Mika [1 ]
Bohara, Manoj [1 ]
Moinuddin, F. M. [1 ]
Kinoshita, Yasuyuki [3 ]
Arita, Kazunori [1 ]
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurosurg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan
[2] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Diabet Metab & Endocrinol, Kagoshima 8908520, Japan
[3] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima 7348551, Japan
关键词
Acromegaly; Growth hormone deficiency; Quality of life; SF-36; Transsphenoidal surgery; GROWTH-HORMONE DEFICIENCY; TREATED PATIENTS; FACTOR-I; MORTALITY; CRITERIA; SURGERY; CURE; CONSENSUS; ACROQOL; EXCESS;
D O I
10.1507/endocrj.EJ16-0182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with acromegaly have a compromised quality of life (QOL). Modem surgical techniques have improved the surgical cure rate. However, there are no prospective studies reporting postoperative changes in QOL among patients cured solely by surgery. The aim of the present study was to determine the effect of surgery on QOL using the 36-item short form health survey (SF-36) questionnaire. SF-36 scores comprise 3 components: the physical component summary (PCS), the mental component summary (MCS) and role-social component summary (RCS). Included in this prospective cohort were 41 patients with acromegaly who underwent surgery alone and achieved postoperative normalization of insulin-like growth factor-1. All participants completed the SF-36 preoperatively and 1 year postoperatively. Preoperatively, RCS and 4 subscale scores (role physical, social functioning, role emotional, mental health) were below the set standards for the normal population. Postoperatively, the PCS and RCS scores did not change significantly, but the MCS score improved significantly (from 48.1 +/- 11.3 to 51.7 +/- 8.9, p=0.03). Further we compared the QOL of 26 patients whose nadir GH level was < 0.4 mu g/L during postoperative oral glucose tolerance testing (complete remission group) with that of 15 patients whose nadir GH level was >= 0.4 mu g/L (partial remission group). There were no significant differences between these groups in terms of PCS, MCS, RCS, or any subscale scores. In conclusion, surgical remission mostly improved the participants' mental condition. There was no difference in QOL between patients who achieved the new remission criteria and those who did not.
引用
收藏
页码:27 / 38
页数:12
相关论文
共 25 条
[1]  
[Anonymous], 2015, MANUAL SF 36V2 JAPAN
[2]   Mortality in 154 surgically treated patients with acromegaly - A 10-year follow-up survey [J].
Arita, K ;
Kurisu, K ;
Tominaga, A ;
Eguchi, K ;
Iida, K ;
Uozumi, T ;
Kasagi, F .
ENDOCRINE JOURNAL, 2003, 50 (02) :163-172
[3]   Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly [J].
Beauregard, C ;
Truong, U ;
Hardy, J ;
Serri, O .
CLINICAL ENDOCRINOLOGY, 2003, 58 (01) :86-91
[4]   Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life [J].
Biermasz, NR ;
Pereira, AM ;
Smit, JWA ;
Romijn, JA ;
Roelfsema, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2731-2739
[5]   Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess [J].
Biermasz, NR ;
van Thiel, SW ;
Pereira, AM ;
Hoftijzer, HC ;
van Hemert, AM ;
Smit, JWA ;
Romijn, JA ;
Roelfsema, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) :5369-5376
[6]   Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas [J].
Campbell, Peter G. ;
Kenning, Erin ;
Andrews, David W. ;
Yadla, Sanjay ;
Rosen, Marc ;
Evans, James J. .
NEUROSURGICAL FOCUS, 2010, 29 (04) :1-8
[7]   Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly [J].
Espinosa-De-Los-Monteros, AL ;
Mercado, M ;
Sosa, E ;
Lizama, O ;
Guinto, G ;
Lopez-Felix, B ;
Garcia, O ;
Hernández, I ;
Ovalle, A ;
Mendoza, V .
JOURNAL OF NEUROSURGERY, 2002, 97 (02) :287-292
[8]   Severe growth hormone deficiency is rare in surgically-cured acromegalics [J].
Fujio, Shingo ;
Tokimura, Hiroshi ;
Hirano, Hirofumi ;
Hanaya, Ryosuke ;
Kubo, Fumikatsu ;
Yunoue, Shunji ;
Bohara, Manoj ;
Kinoshita, Yasuyuki ;
Tominaga, Atsushi ;
Arimura, Hiroshi ;
Arita, Kazunori .
PITUITARY, 2013, 16 (03) :326-332
[9]   Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan [J].
Fukuhara, S ;
Bito, S ;
Green, J ;
Hsiao, A ;
Kurokawa, K .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1037-1044
[10]   The Treatment of De Novo Acromegalic Patients with Octreotide-LAR: Efficacy, Tolerability and Cardiovascular Effects [J].
J. Gilbert ;
M. Ketchen ;
P. Kane ;
T. Mason ;
E. Baister ;
M. Monaghan ;
S. Barr ;
P.E. Harris .
Pituitary, 2003, 6 (1) :11-18